Ticker Details
Kyverna Therapeutics, Inc. Common Stock
IPO Date:	February 9, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$527.09M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.35 | 4.47%
Avg Daily Range (30 D):	$0.41 | 4.21%
Avg Daily Range (90 D):	$0.37 | 4.09%

Institutional Daily Volume
Avg Daily Volume:	.55M
Avg Daily Volume (30 D):	1.09M
Avg Daily Volume (90 D):	.8M

Trade Size
Avg Trade Size (Sh.):	97
Avg Trade Size (Sh.) (30 D):	83
Avg Trade Size (Sh.) (90 D):	84

Institutional Trades
Total Institutional Trades:	158
Avg Institutional Trade:	$1.71M
Avg Institutional Trade (30 D):	$.72M
Avg Institutional Trade (90 D):	$.9M
Avg Institutional Trade Volume:	.16M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.13M
Avg Closing Trade (30 D):	$.77M
Avg Closing Trade (90 D):	$1.09M
Avg Closing Volume:	215.88K

News

May 14, 2026 @ 12:00 PM Kyverna Therapeutics to Present at Upcoming Invest... Source: Na

Apr 21, 2026 @ 10:45 PM Kyverna Presents Registrational Trial Primary Anal... Source: Na

Feb 24, 2026 @ 1:00 PM Kyverna Therapeutics Appoints Biotech Leaders Srav... Source: Na

Dec 31, 2025 @ 3:01 PM How M&A Unlocked A Biotech Rebound In 2025—... Source: Namrata Sen

Dec 17, 2025 @ 2:24 PM Kyverna Therapeutics Announces Pricing of $100 Mil... Source: Globe Newswire

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-3.27	$-.66	$-.79
Diluted EPS	$-3.27	$-.66	$-.79
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-156.4M	$-39.73M	$-37.8M
Operating Income / Loss	$-163.79M	$-41.37M	$-39.28M
Cost of Revenue
Net Cash Flow	$-24.68M	$-91.9M	$89.93M
PE Ratio